Vetgrad logo
VetGrad Ask An Expert Sign in Register for FREE Forum Competition VetGrad Offers Contact Us
Search
Powered by Google
Latest News
Home

Home

10 Minute Top Up

CPD

Resources

How To

YVN

Need to Know

Jobs

Oops

PDP/PDR

Why Bother?


Ask An Expert

Sign in

Register for FREE

Forum

Competition

VetGrad Offers

Contact Us

Ceva Animal health has introduced Marbox®, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. Marbox® effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.

 

Mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox® can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.

 

Marbox® is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.

 

Marbox® can be used in combination with Meloxidyl®, Ceva’s new, single shot anti-inflammatory. The product joins Ceva’s popular bovine range of anti-infectives, which includes Cevaxel®, Florkem® and Spectam® Injectable.

 

For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com

Follow us:
Share this page: